Inventor profile of:

William E. KLUNK

City:

Pittsburgh, Pennsylvania

Country:

United States

Published Applications:

25

Last publication date:

2018-02-01

Top Assignees for applications by William E. KLUNK

The entities that hold a legal rights for patent applications filed by inventor KLUNK William E.:

Recent patent applications by KLUNK William E.

William E. KLUNK from Pittsburgh, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-02-01
US20180028694A1
Human necessities

Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition

#2 | 2015-07-09
US20150190400A1
Human necessities

Thioflavin derivatives for use in the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition

#3 | 2015-06-18
US20150165073A1
Human necessities

Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition

#4 | 2014-08-07
US20140220590A1
Physics

Methods of using benzothiazole derivative compounds and compositions

#5 | 2014-04-17
US20140105820A1
Human necessities

AMYLOID IMAGING AS A SURROGATE MARKER FOR EFFICACY OF ANTI-AMYLOID THERAPIES

#6 | 2013-09-12
US20130236394A1
Human necessities

Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition

#7 | 2013-02-21
US20130045164A1
Human necessities

Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies

#8 | 2013-01-03
US20130004422A1
Physics

Benzothiazole derivative compounds, compositions and uses

#9 | 2012-07-26
US20120189545A1
Chemistry; metallurgy

ISOTOPICALLY-LABELED BENZOFURAN COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS

#10 | 2012-07-12
US20120177572A1
Human necessities

Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies

#11 | 2012-06-14
US20120148494A1
Chemistry; metallurgy

ISOTOPICALLY-LABELED BENZOFURAN COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS

#12 | 2012-04-19
US20120095235A1
Human necessities

THIOFLAVIN DERIVATES FOR USE IN THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER'S DISEASE AND IN VIVO IMAGING AND PREVENTION OF AMYLOID DEPOSITION

#13 | 2011-10-20
US20110257407A1
Human necessities

Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition

#14 | 2010-01-28
US20100021388A1
Physics

Benzothiazole derivative compounds, compositions and uses

#15 | 2009-06-04
US20090142269A1
Chemistry; metallurgy

ISOTOYPICALLY-LABELED BENZOTHIAZOLE COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS

#16 | 2009-04-02
US20090087376A1
Chemistry; metallurgy

Heterocyclic Dye Compounds For In Vivo Imaging And Diagnosis Of Alzheimer's Disease

#17 | 2008-12-11
US20080305040A1
Physics

In Vivo or in Vitro Method For Detecting Amyloid Deposits Having at Least One Amyloidogenic Protein

#18 | 2008-11-20
US20080286202A1
Human necessities

Method of Diagnosing Prodromal Forms of Diseases Associated With Amyloid Deposition

#19 | 2008-11-06
US20080274058A1
Chemistry; metallurgy

Isotopically-labeled benzofuran compounds as imaging agents for amyloidogenic proteins

#20 | 2008-09-11
US20080219931A1
Human necessities

Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies

#21 | 2008-06-26
US20080154042A1
Human necessities

THIOFLAVIN DERIVATIVES FOR USE IN THE ANTEMORTEM DIAGNOSIS OF ALZHEIMERS DISEASE AND IN VIVO IMAGING AND PREVENTION OF AMYLOID DEPOSITION

#22 | 2008-01-24
US20080021077A1
Human necessities

Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition

#23 | 2007-09-18
US10388173
-

Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition

#24 | 2005-02-24
US20050043523A1
Physics

Benzothiazole derivative compounds, compositions and uses

#25 | 2005-02-24
US20050043377A1
Human necessities

Thioflavin derivatives for use in the antemortem diagnosis of Alzheimers disease and in vivo imaging and prevention of amyloid deposition

InventorID:

10379 ⎘